{"id":114044,"date":"2021-05-11T10:33:34","date_gmt":"2021-05-11T10:33:34","guid":{"rendered":"https:\/\/fin2me.com\/?p=114044"},"modified":"2021-05-11T10:33:34","modified_gmt":"2021-05-11T10:33:34","slug":"pfizer-q1-profit-rises-lifts-fy-outlook","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/","title":{"rendered":"Pfizer Q1 Profit Rises; Lifts FY Outlook"},"content":{"rendered":"

Pfizer Inc. (PFE) reported a profit for the first-quarter that increased 45 percent from last year. It raised 2021 guidance driven by the updated expectations for contributions to 2021 performance from COVID-19 vaccine, as well as the strong performance of the business<\/span>, partially offset by anticipated additional R&D investments into vaccines to protect against COVID-19.<\/p>\n

Quarterly revenues rose 45 percent from the prior year. The company reported $3.5 billion in first-quarter sales of its COVID-19 vaccine.<\/p>\n

The company raised its fiscal year 2021 adjusted earnings per share outlook to a range of $3.55 – $3.65 from the prior outlook of $3.10 – $3.20. Analysts expect annual earnings of $3.36 per share.<\/p>\n

The company also increased its annual revenues guidance to a range of $70.5 billion – $72.5 billion from the prior estimation of $59.4 billion – $61.4 billion. Analysts expect revenues of $62.99 billion.<\/p>\n

The company now expects full-year sales of $26 billion from the COVID-19 vaccine, up from its previous forecast of about $15 billion, reflecting 1.6 billion doses expected to be delivered in 2021 under signed contracts as of mid-April 2021.<\/p>\n

Pfizer’s first-quarter net income attributable to common shareholders grew 45 percent to $4.88 billion from the previous year’s $3.36 billion, with earnings per share improving to $0.86 from $0.60 last year.<\/p>\n

Adjusted net income was $0.93 compared to $0.63 in the previous year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.78 per share for the first-quarter. Analysts’ estimates typically exclude special items.<\/p>\n

Revenues for the first-quarter were $14.6 billion, an increase of $4.5 billion, or 45 percent, from the prior-year quarter, reflecting operational growth of $4.2 billion, or 42 percent, as well as a favorable impact of foreign exchange of $284 million, or 3%. Analysts expected revenues of $13.6 billion for the quarter.<\/p>\n

First-quarter 2021 operational growth was primarily driven by BNT162b2, which contributed $3.5 billion in global revenues.<\/p>\n

In Tuesday pre-market trade, PFE was trading at $40.34 up $0.51 or 1.28 percent. <\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Pfizer Inc. (PFE) reported a profit for the first-quarter that increased 45 percent from last year. It raised 2021 guidance driven by the updated expectations […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"yoast_head":"\nPfizer Q1 Profit Rises; Lifts FY Outlook - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Q1 Profit Rises; Lifts FY Outlook - Fin2me\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc. (PFE) reported a profit for the first-quarter that increased 45 percent from last year. It raised 2021 guidance driven by the updated expectations [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-11T10:33:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2018\/07\/5b4326342000004100b9677b.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1910\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/\",\"url\":\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/\",\"name\":\"Pfizer Q1 Profit Rises; Lifts FY Outlook - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-05-11T10:33:34+00:00\",\"dateModified\":\"2021-05-11T10:33:34+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business\",\"item\":\"https:\/\/fin2me.com\/category\/business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pfizer Q1 Profit Rises; Lifts FY Outlook\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Q1 Profit Rises; Lifts FY Outlook - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Q1 Profit Rises; Lifts FY Outlook - Fin2me","og_description":"Pfizer Inc. (PFE) reported a profit for the first-quarter that increased 45 percent from last year. It raised 2021 guidance driven by the updated expectations [...]","og_url":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/","og_site_name":"Fin2me","article_published_time":"2021-05-11T10:33:34+00:00","og_image":[{"width":1910,"height":1000,"url":"https:\/\/fin2me.com\/wp-content\/uploads\/2018\/07\/5b4326342000004100b9677b.jpeg","type":"image\/jpeg"}],"author":"Mark","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/","url":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/","name":"Pfizer Q1 Profit Rises; Lifts FY Outlook - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-05-11T10:33:34+00:00","dateModified":"2021-05-11T10:33:34+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/business\/pfizer-q1-profit-rises-lifts-fy-outlook\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Business","item":"https:\/\/fin2me.com\/category\/business\/"},{"@type":"ListItem","position":3,"name":"Pfizer Q1 Profit Rises; Lifts FY Outlook"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/114044"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=114044"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/114044\/revisions"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=114044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=114044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=114044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}